Latest Articles
-
This Stock Is Likely To Outperform Medtronic
We think that Intuitive Surgical stock (NASDAQ: ISRG) is currently is a better pick compared to Medtronic stock (NYSE: MDT), despite Intuitive Surgical being the more expensive of the two. ISRG trades at about 23x trailing revenues, compared to ...
-
Is There More Room For Growth In Medtronic Stock?
[Updated: Aug 25, 2021] Medtronic Stock Update Medtronic (NYSE:MDT) recently reported its fiscal Q1 2022 results, which were better than our estimates. The company reported revenues of $8.0 billion, slightly above ours and the consensus estimat...
-
What To Expect From Medtronic’s Q1?
Medtronic stock (NYSE: MDT) is scheduled to report its fiscal first-quarter results on Tuesday, Aug 24. We expect Medtronic to likely post revenues and earnings largely in-line with the consensus estimates. The company is likely to benefit from a...
-
Forecast Of The Day: Medtronic Surgical Innovations Revenue
What? Trefis expects Medtronic’s (NYSE:MDT) Surgical Innovations revenue – which includes surgical stapling devices, vessel sealing instruments, wound closure, and related products – to remain roughly flat at around $5.5 billi...
-
Medtronic Stock Remains Attractive At $125 Levels
[Updated: 6/25/2021] Medtronic Update Medtronic stock (NYSE: MDT) has seen an 8% rise so far this year, slightly underperforming the broader markets with the S&P 500 up 15%. While the Covid-19 pandemic weighed on the company’s perform...
-
What To Expect From Medtronic’s Q4?
Medtronic stock (NYSE: MDT) is scheduled to report its fiscal fourth-quarter results on Thursday, May 27. We expect Medtronic to likely post revenues and earnings below the consensus estimates. While the company is likely to benefit from an impro...
-
Should You Buy Medtronic At $117?
Medtronic (NYSE: MDT) looks attractive at current levels of $117, as it is up 60% from the levels it was at on March 23, 2020, when broader markets made a bottom due to the spread of Covid-19. This marks an underperformance compared to the S&...
-
What To Expect From Medtronic Stock In Q3?
Medtronic stock (NYSE: MDT) is scheduled to report its fiscal third-quarter results on Tuesday, February 23. We expect Medtronic to likely post revenues in-line, and earnings above the consensus estimates. Revenue growth is likely to be driven by...
-
3M Stock Can Offer Better Gains Compared To Medtronic
We think that 3M (NYSE: MMM) currently is a better pick compared to Medtronic (NYSE: MDT) . 3M trades at about 3.1x trailing Revenues, compared to over 5.4x for Medtronic, though both belong to different industry groups. But does this gap in 3...
-
Further Upside For Medtronic Stock
We believe that Medtronic stock (NYSE: MDT) is a good buying opportunity at the present time. MDT stock trades near $115 currently and it is, in fact, down 6% from its pre-Covid high of $121 in February 2020 – just before the coronavirus pandemi...
-
Earnings Beat On The Cards For Medtronic Stock?
Medtronic (NYSE: MDT) is scheduled to report its fiscal Q2 2021 results on Tuesday, November 24. We expect Medtronic to likely beat the revenue and earnings expectations, driven by improved demand for medical devices with an increase in the numbe...
-
Medtronic Stock Appears Attractive Around $100 Levels
We believe that Medtronic stock (NYSE:MDT) could offer an upside of roughly 15% from the current levels. MDT stock trades at $102 currently and it is down 9% so far this year as well as from the pre-Covid high of $112 seen in February. Also, M...
-
Medtronic Stock Looks Attractive At $107
Despite a 46% rise since the March 23 lows of this year, at the current price of around $107 per share we believe Medtronic’s stock (NYSE: MDT) looks attractive and it has more room for growth. MDT stock has moved from $73 to $107 off the r...
-
Should Medtronic Investors Hold On To The Stock?
Medtronic (NYSE:MDT) stock lost more than 35% this year, declining from $115 to $73. Interestingly, it has since spiked a little over 25% to around $92 (as of July 8, 2020). This means that the stock is about 20% below where it was at the beginn...
-
Could Medtronic Stock See A 35% Decline From Current Levels?
Despite a 17% decline in Medtronic’s stock (NYSE: MDT) since the beginning of the year, at the current price of around $95, Medtronic’s stock could see a significant downside, due to the impact of the coronavirus crisis. Medtronic has...
